Goldman Sachs’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-798,544
Closed -$16.1M 5818
2021
Q3
$16.1M Buy
798,544
+188,090
+31% +$3.79M ﹤0.01% 1907
2021
Q2
$22.8M Sell
610,454
-458,115
-43% -$17.1M 0.01% 1644
2021
Q1
$27.3M Sell
1,068,569
-10,304
-1% -$263K 0.01% 1456
2020
Q4
$23.8M Buy
1,078,873
+377,291
+54% +$8.31M 0.01% 1446
2020
Q3
$12.6M Buy
701,582
+176,149
+34% +$3.17M ﹤0.01% 1782
2020
Q2
$13.3M Sell
525,433
-676,674
-56% -$17.2M ﹤0.01% 1761
2020
Q1
$22.1M Buy
1,202,107
+441,229
+58% +$8.11M 0.01% 1262
2019
Q4
$16.8M Sell
760,878
-22,139
-3% -$488K ﹤0.01% 1735
2019
Q3
$11.2M Sell
783,017
-551,629
-41% -$7.92M ﹤0.01% 1861
2019
Q2
$21M Buy
1,334,646
+220,898
+20% +$3.48M 0.01% 1554
2019
Q1
$16.3M Sell
1,113,748
-118,514
-10% -$1.74M ﹤0.01% 1740
2018
Q4
$13.2M Sell
1,232,262
-124,522
-9% -$1.33M ﹤0.01% 1783
2018
Q3
$20.7M Buy
1,356,784
+804,970
+146% +$12.3M 0.01% 1618
2018
Q2
$6.76M Sell
551,814
-236,790
-30% -$2.9M ﹤0.01% 2243
2018
Q1
$7.54M Buy
788,604
+594,406
+306% +$5.68M ﹤0.01% 2102
2017
Q4
$1.75M Buy
194,198
+88,778
+84% +$802K ﹤0.01% 2894
2017
Q3
$606K Buy
+105,420
New +$606K ﹤0.01% 3439
2017
Q1
Sell
-24,286
Closed -$70K 4591
2016
Q4
$70K Sell
24,286
-18,855
-44% -$54.3K ﹤0.01% 4181
2016
Q3
$254K Sell
43,141
-328
-0.8% -$1.93K ﹤0.01% 3784
2016
Q2
$130K Buy
43,469
+12,297
+39% +$36.8K ﹤0.01% 4032
2016
Q1
$167K Buy
31,172
+15,373
+97% +$82.4K ﹤0.01% 3858
2015
Q4
$188K Buy
15,799
+2,567
+19% +$30.5K ﹤0.01% 3768
2015
Q3
$109K Sell
13,232
-10,402
-44% -$85.7K ﹤0.01% 4133
2015
Q2
$330K Buy
+23,634
New +$330K ﹤0.01% 3645
2014
Q2
Sell
-9,079
Closed -$256K 4534
2014
Q1
$256K Buy
+9,079
New +$256K ﹤0.01% 3774